story of the week
Effect of Dapagliflozin Across the Range of LVEF in Patients With Heart Failure
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Nat. Med. 2022 Aug 27;[EPub Ahead of Print], PS Jhund, T Kondo, JH Butt, KF Docherty, BL Claggett, AS Desai, M Vaduganathan, SB Gasparyan, O Bengtsson, D Lindholm, M Petersson, AM Langkilde, RA de Boer, D DeMets, AF Hernandez, SE Inzucchi, MN Kosiborod, L Køber, CSP Lam, FA Martinez, MS Sabatine, SJ Shah, SD Solomon, JJV McMurrayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.